| Publication date | Issuer | Person discharging managerial responsibilities | Position | Closely associated | Nature of transaction | Instrument name | Intrument type | ISIN | Transaction date | Volume | Unit | Price | Currency | Status | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29/11/2016 | NeuroVive Pharmaceutical AB | MATS ESKIL ELMÉR | Forskningschef | Acquisition | NeuroVive Pharmaceutical AB | SE0002575340 | 25/11/2016 | 6,000 | Quantity | 3.35 | SEK | Notification | |||
| 29/11/2016 | NeuroVive Pharmaceutical AB | MATS ESKIL ELMÉR | Forskningschef | Acquisition | NeuroVive Pharmaceutical AB | SE0002575340 | 25/11/2016 | 25,000 | Quantity | 3.45 | SEK | Notification | |||
| 29/11/2016 | NeuroVive Pharmaceutical AB | MATS ESKIL ELMÉR | Forskningschef | Acquisition | NeuroVive Pharmaceutical AB | SE0002575340 | 28/11/2016 | 4,000 | Quantity | 3.40 | SEK | Notification |